Another successful @CTFRide 2025 with Chief @DrRoyHerbstYale PD Dr. Hurwitz APD Dr. Podoltsev Fellows @ncasasanta @StockhammerPaul @RSharma128

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️

What an incredible opportunity the Dixwell Community House provided chief @KwarambaT90 to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.

https://t.co/UJP90LQy9o

@YaleCancer @YaleMed @ASCO annual meeting #Day4 poster presentations 👏🏼

Look at this legend, literally juggling two posters at the same time on "A Phase II Study of Olaparib in IDH1 and IDH2 Mutant Chondrosarcomas and Other Solid tumors" and "A Phase 2 Study of Olaparib and Ceralasertib in IDH mutant Solid Tumors" at #ASCO25. Dr. Costa, a legend.

Dr. Yochum will always impress! He presented this morning on "Assessment of time- to- treatment- failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic RCC: Findings from an IMDC analysis" at #ASCO25. In awe.

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!

This afternoon at 1:30pm CDT #ASCO25, @JuanJVelasco, @KwarambaT90, and @CostaPhilippos share new research advances from Yale in the final poster session of the day. @SmilowCancer @YaleMed @YNHH @YaleHemOnc

On National #CancerSurvivorsDay, @KwarambaT90 presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 @YaleHemOnc @SmilowCancer @OncoAlert https://t.co/fZwf7OjUII

Dr. Perry's oral presentation on "Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinoma" at #ASCO25 was FA-BU-LOUS! Curt, you're awe-inspiring! @curtperrymdphd @ynie_md @KwarambaT90

Go Curt go! @curtperrymdphd

#ASCO2025 gives us the excuse to catch up with former chiefs, Dr. Fanucci and Dr. Ansari who are now in Boston and Kansas City respectively. They are so fabulous, you have no idea!

Great research presentations continue this morning at #ASCO25 with posters from @livlynch18, @KwarambaT90, @danoneilmd1, and @JacquelyneGMD. Stop in to Hall A starting at 9am CDT! @SmilowCancer @YaleMed @YNHH @YaleHemOnc

In classic Alfred Lee-style, a Yale trainee selfie for your pleasure at #ASCO25. We're having a blast! @ynie_md @KwarambaT90

Dr. Yasin brilliantly presented on "Comparison of MET Genomic Alterations Identified in Colorectal Cancer vs Gastric Cancer" this morning at #ASCO25. A GI oncology rockstar right here! @faizayasin_md

Dr. Nassar is at it again. Presenting on "Association of ctDNA VAF with Outcomes on Matched Targeted Therapies in Advanced Non-small Cell Lung Cancer" at #ASCO25. What a legend!

Look at the engagement by Dr. Nie presenting on "Clinical features associated with exceptional response to immunotherapy in patients with non- small cell lung cancer" at #ASCO25. What a star!

Dr. Wang is a constant vibe! Presenting on "Use of Targeted Therapy in Patients with Advanced Non-small Cell Lung Cancer in Response to Broad Genomic Profiling" at #ASCO25. A vibe I say!